Back to Journals
Clinical Pharmacology: Advances and Applications
Chief of medical oncology, USA Mitchell Cancer Institute, Alabama, USA, United States
Editor-in-Chief: Arthur E Frankel
Arthur E. Frankel, MD was born in Austin, Texas, attended Harvard College and Harvard Medical School and completed medical training at Yale University, the National Institutes of Health and Stanford University. He practiced and taught at Duke University, the Medical University of South Carolina, Wake Forest University, Texas A&M, the University of Texas Southwestern, and the University of South Alabama. He is now Chief Hematology and Oncology at the West Palm Beach VA Medical Center. His clinical focus is malignant hematology, cutaneous malignancies and GU cancers. He has done research including the discovery of the first mammalian oncogenes, the generation of the first Her2 and PSA monoclonal antibodies, the finding of one of the first second site revertant enzyme mutations, discovery of a third lectin binding site on the plant toxin ricin, production of anti-leukemia fusion proteins, and reporting the first gut microbes critical for melanoma immunotherapy response. His interleukin 3-directed fusion protein was approved by the FDA in 2018 for a rare type of leukemia. His current goal is to provide outstanding and cutting edge clinical care to veterans.
Pharmaceutics, University of Mississippi, United States
Associate Editor: Dr S Narasimha Murthy
Dr S Narasimha Murthy is an Associate Professor of Pharmaceutics at the University of Mississippi. His Masters and Ph.D research at Bangalore University, India, focused on Development of Transdermal Drug Delivery Systems for prolonged delivery of antiasthmatic drugs. During his postdoctoral research at the Roswell Park Cancer Institute, Buffalo, NY, USA. Dr Murthy worked on active dermal and transdermal drug delivery techniques such as iontophoresis and electroporation.
His Research group (http://www.olemiss.edu/~murthy) at the University of Mississippi continues to work on the development of novel formulations and technologies for the drug delivery into skin and nail apparatus.
Dr Murthy has published over 50 research papers in peer-reviewed journals and presented over 70 papers in various national and international scientific conferences. He has edited two textbooks titled “Dermatokinetics of Therapeutic agents” and “Ungual and Trans-Ungual delivery of Drugs”. He regularly serves as reviewer of grant proposals for International Research Foundations and National Institutes of Health, USA. He is currently serving as manuscript reviewer and Editorial Board member in about twenty pharmaceutical journals. He also has several awards and recognitions to his credit. He is a member of Controlled Release Society and Chair-Elect of Dermatopharmaceutics focus group of American Association of Pharmaceutical Scientists.
William C. Cho, Ph.D., Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, People's Republic of China.
James M. Cook, University Distinguished Professor, Organic Chemistry, Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA
Esam Z. Dajani, President, IDDC Corporation; Adjunct Professor of Medicine, Loyola University-Chicago, Chicago, Illinois, USA
Nicholas S. Duesbery, Department of Research, Spectrum Health Hospital, Grand Rapids, MI, USA
M. Elizabeth Fini, Professor of Cell and Neurobiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA
Prof. Dr. Foldvari
Marianna Foldvari, Professor of Pharmaceutical Sciences, School of Pharmacy, University of Waterloo, ON, Canada
Hendrik Fuchs, Professor for Target Cell Directed Tumor Therapy, Head of the Laboratory of Molecular Tumor Therapy and Deputy Director of the Department of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Germany.
Ramesh Ganju, Scott Endowed Professor of Pathology, Vice-Chair Experimental Pathology, Ohio State University, Columbus, OH, USA
Paul L Kaufman, Ernst H. Bárány Professor of Ocular Pharmacology Emeritus, Department Chair Emeritus, Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Robert J. Kreitman, Chief, Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Edythe D. London PhD. Katherine K. and Thomas P. Pike Professor of Addiction Studies, Distinguished Professor of Psychiatry and Biobehavioral Sciences, and of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, USA
William G. North, Professor of Physiology, Department of Molecular and Systems Biology, Geisel School of Medicine at Dartmouth College, Hanover NH USA
Hui-Lin Pan, Helen T. Hawkins Distinguished Professor and Deputy Division Head for Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Bruce G. Pollock, Professor of Psychiatry & Pharmacology, University of Toronto, Faculty of Medicine, Vice President, Research & Director, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, Canada
Eva E. Redei, Ph.D.David Lawrence Stein Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University
Scot C. Remick, MD, Chief, MaineHealth Cancer Care Network, Maine Medical Center Cancer Institute, Portland, ME; Professor Tufts University School of Medicine, Boston MA, USA
Mandip Singh Sachdeva, Professor, Pharmaceutics, College of Pharmacy, Florida A&M University, FL, USA
Stephen H. Safe, Distinguished Professor, Department of Veterinary Physiology and Pharmacology, Texas A&M University and Health Science Center, College Station, TX, USA
Daniel A. Vallera, Professor of Therapeutic Radiology - Radiation Oncology, Lion Scholar and Director, Section on Molecular Cancer Therapeutics, University of Minnesota Cancer Center, Minnesota, USA
Donna Wang, Distinguished Professor, Chief, Division of Nanomedicine and Molecular Intervention, Michigan State University, East Lansing, Michigan, USA
Jung Hee Woo, Director of Cancer Research Institute/Associate Professor, Cancer Research Institute/Department of Internal Medicine, Baylor Scott and White Health, Texas A&M University System Health Science Center, Temple, TX, USA